Abstract
Intro: There is profuse research to support PR in chronic lung conditions. Most effective rehab for C-19 survivors remains unknown with no evidence PR is useful. SARS/MERS data suggests that PR might be valuable. Equally, parallels between chronic lung conditions and C-19, suggest some clinical reasoning to support adapting current programmes for survivors (BTS July 2020). 30% of those seen at 12weeks were referred to PR.
Aim: To establish PR effectiveness in survivors of C-19.
Method: People admitted with severe C-19 pneumonia were seen 12weeks post-discharge as per BTS guidelines. This includes those requiring mechanical ventilation, CPAP, NIV, NHFO or FiO2 >40%. At 12weeks, suitable people were offered 6weeks PR. Adaptations to exercise and education provided were from emerging guidance.
Results: Complete data was available for n=15 (9males, mean age 61years).
MRC, PCFS, CRQ, mood questionnaires, 6MWT were recorded.
shows mean scores pre and post PR. Wilcoxon** and paired t-test* were used with significance value p=0.05.
Conclusion: Initial results in a small group are positive for PR assisting recovery in C-19 survivors. With statistically significant differences in all bar two outcome measures. We hope to continue to offer PR post severe C-19 pneumonia as cases rise as early analysis has shown good effectiveness minus adverse effect.
Footnotes
Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA2264.
This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2021
